Biomarkers for mortality prognosis in critically ill patients
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIV
- Publication Date
- 2022-08-05
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] cross reference
[0002] This application requires the equity of the US temporary application in the United States temporarily submitted on June 26, 2016, which is incorporated into this article by reference.
[0003] Statement on the research or research on federal government funding
[0004] The invention is completed by the government support of the contracts AI057229, AI089859, AI109662, and AI117925 awarded by the National Institute of Health Research. The government has some rights invented. Technical field
[0005] The present invention generally involves the prognosis of the risk of death in critical patients. Specifically, the invention involves the purpose of biomarkers, which can be used for the prognosis of death risk of critical patients who have pyunda, severe trauma or burns. Background technique
[0006] Pyxiaxia, organ failure caused by new definitions to infected systemic reactions 1 It caused half of the deaths in all hospitals in the United States and ...